[
  {
    "ts": "2025-04-02T12:00:00+00:00",
    "headline": "Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test",
    "summary": "WALTHAM, Mass., April 02, 2025--Revvity, Inc. (NYSE: RVTY), today announced that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT™.TB test. Initially launched outside the U.S. in 2024, this powerful combination allows laboratories to improve productivity while maintaining superior clinical performance in latent tuberculosis (TB) detection. This milestone marks a significant advancement in the fight against TB with a faster high-",
    "url": "https://finance.yahoo.com/news/revvity-secures-fda-approval-improved-120000223.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "02b87f5b-449f-3861-9b1b-93bb61b816c6",
      "content": {
        "id": "02b87f5b-449f-3861-9b1b-93bb61b816c6",
        "contentType": "STORY",
        "title": "Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test",
        "description": "",
        "summary": "WALTHAM, Mass., April 02, 2025--Revvity, Inc. (NYSE: RVTY), today announced that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT™.TB test. Initially launched outside the U.S. in 2024, this powerful combination allows laboratories to improve productivity while maintaining superior clinical performance in latent tuberculosis (TB) detection. This milestone marks a significant advancement in the fight against TB with a faster high-",
        "pubDate": "2025-04-02T12:00:00Z",
        "displayTime": "2025-04-02T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/038bf4887b263b479f7a9905dee1f089",
          "originalWidth": 784,
          "originalHeight": 320,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xGycPbNnDThLufJaDik3mQ--~B/aD0zMjA7dz03ODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/038bf4887b263b479f7a9905dee1f089.cf.webp",
              "width": 784,
              "height": 320,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G9_o5kHLPIVANheSb6W9vg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/038bf4887b263b479f7a9905dee1f089.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/revvity-secures-fda-approval-improved-120000223.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/revvity-secures-fda-approval-improved-120000223.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVTY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-04-02T11:47:00+00:00",
    "headline": "Here's Why You Should Retain Revvity Stock in Your Portfolio for Now",
    "summary": "RVTY's strong product portfolio raises optimism about the stock.",
    "url": "https://finance.yahoo.com/news/heres-why-retain-revvity-stock-114700572.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "1565614e-ea94-335c-a515-6f18ca85c6ab",
      "content": {
        "id": "1565614e-ea94-335c-a515-6f18ca85c6ab",
        "contentType": "STORY",
        "title": "Here's Why You Should Retain Revvity Stock in Your Portfolio for Now",
        "description": "",
        "summary": "RVTY's strong product portfolio raises optimism about the stock.",
        "pubDate": "2025-04-02T11:47:00Z",
        "displayTime": "2025-04-02T11:47:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-revvity-stock-114700572.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-revvity-stock-114700572.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVTY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]